DCAF7 and neoplasm: In LIHC, DCAF7 correlated strongly with PD‐1/PD‐L1 and CTLA‐4 expression, implying that tumours with elevated DCAF7 might preferentially exploit checkpoint pathways for immune evasion and could therefore benefit from dual targeting of DCAF7‐driven signalling and checkpoint blockade.